J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e ● C o n t e n t s ● C u r r e n t e v e n t s ● R a n d o m a r t i c l e ● A b o u t W i k i p e d i a ● C o n t a c t u s ● D o n a t e
C o n t r i b u t e
● H e l p ● L e a r n t o e d i t ● C o m m u n i t y p o r t a l ● R e c e n t c h a n g e s ● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t ● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t ● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e ● C o n t r i b u t i o n s ● T a l k
( T o p )
1 C o m p a n y h i s t o r y
2 P h y t o p h a r m
3 R e f e r e n c e s
T o g g l e t h e t a b l e o f c o n t e n t s
I X I C O
A d d l a n g u a g e s
A d d l i n k s
● A r t i c l e ● T a l k
E n g l i s h
● R e a d ● E d i t ● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d ● E d i t ● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e ● R e l a t e d c h a n g e s ● U p l o a d f i l e ● S p e c i a l p a g e s ● P e r m a n e n t l i n k ● P a g e i n f o r m a t i o n ● C i t e t h i s p a g e ● G e t s h o r t e n e d U R L ● D o w n l o a d Q R c o d e ● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F ● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
( R e d i r e c t e d f r o m P h y t o p h a r m )
IXICO Company type Public limited company
Traded as
LSE:IXI Industry Data analytics for clinical research Founded 2004 Founders Professors Derek Hill, Daniel Rueckert , David Hawkes and Jo Hajnal Headquarters
London
,
United Kingdom
Area served
Worldwide
Key people
Charles Spicer (Chairman) Website https://ixico.com/
IXICO plc is a UK clinical research firm that provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials into neurological diseases such as Alzheimer's disease (AD ) and Huntington's disease (HD ).
Company history
[ edit ]
IXICO was incorporated in 2004[1] Imperial College London , University College London and King's College London .[2] UK e-science core and other industry partners.[3]
In October 2013, IXICO entered the Alternative Investment Market (AIM) of the London Stock Exchange through a reverse takeover of defunct pharmaceutical drug company Phytopharm.[4]
Phytopharm
[ edit ]
Phytopharm was a British pharmaceutical company , incorporated on 28 November 1995. Briefly known as Lawnhale, it changed its name to Phytopharm in March 1996[5] [6] NASDAQ in 2004 (NASDAQ:PHYOF).[7] [8]
Amongst other activity, Phytopharm raised funds for research into treatment of Parkinson's disease (PD ) from sources including the Michael J Fox Foundation ,[9] [10] [11] [12]
References
[ edit ]
^ "What is IXI?" . www0.cs.ucl.ac.uk . Retrieved 30 November 2018 .
^ "Phytopharm plc to be renamed IXICO plc on admission - London Stock Exchange" . www.londonstockexchange.com . Retrieved 30 November 2018 .
^ "IXICO PLC - Overview (free company information from Companies House)" . beta.companieshouse.gov.uk . Retrieved 4 December 2018 .
^ "Resources" .
^ "Phytopharm turns to Nasdaq in search for US investors" . The Independent . Retrieved 4 December 2018 .
^ "Phytopharm PLC Preliminary Results" . ADVFN . Retrieved 4 December 2018 .
^ "Phytopharm turns to Nasdaq in search for US investors" . The Independent . Retrieved 4 December 2018 .
^ "Cogane for Parkinson's Shows No Benefit over Placebo in Clinical Trial" . The Michael J. Fox Foundation for Parkinson's Research | Parkinson's Disease . Retrieved 4 December 2018 .
^ "Phytopharm (PYM) Share Price" . ADVFN . Retrieved 4 December 2018 .
^ "Phytopharm suspends shares pending acquisition | Business Weekly | Technology News | Business news | Cambridge and the East of England" . www.businessweekly.co.uk . Retrieved 4 December 2018 .
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=IXICO&oldid=1225861673 " C a t e g o r i e s : ● B i o t e c h n o l o g y c o m p a n i e s o f t h e U n i t e d K i n g d o m ● B r i t i s h c o m p a n i e s e s t a b l i s h e d i n 2 0 0 4 ● T e c h n o l o g y c o m p a n i e s b a s e d i n L o n d o n ● C o m p a n i e s l i s t e d o n t h e A l t e r n a t i v e I n v e s t m e n t M a r k e t H i d d e n c a t e g o r i e s : ● A r t i c l e s w i t h s h o r t d e s c r i p t i o n ● S h o r t d e s c r i p t i o n m a t c h e s W i k i d a t a ● U s e d m y d a t e s f r o m D e c e m b e r 2 0 1 8 ● U s e B r i t i s h E n g l i s h f r o m D e c e m b e r 2 0 1 8 ● A r t i c l e s w i t h I S N I i d e n t i f i e r s
● T h i s p a g e w a s l a s t e d i t e d o n 2 7 M a y 2 0 2 4 , a t 0 5 : 0 0 ( U T C ) . ● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n . ● P r i v a c y p o l i c y ● A b o u t W i k i p e d i a ● D i s c l a i m e r s ● C o n t a c t W i k i p e d i a ● C o d e o f C o n d u c t ● D e v e l o p e r s ● S t a t i s t i c s ● C o o k i e s t a t e m e n t ● M o b i l e v i e w
